Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts
Crossref DOI link: https://doi.org/10.1186/s12967-015-0553-6
Published Online: 2015-06-13
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Woan-Ruoh
Shen, Shing-Chuan
Shih, Yi-Hsien
Chou, Chia-Lun
Tseng, Jonathan Te-Peng
Chin, Szu-Ying
Liu, Kao-Hui
Chen, Yen-Chou
Jiang, Ming-Chung